The Dutch government is proposing Amsterdam as the new headquarters for the European Medicines Agency (EMA), emphasizing the need for business continuity during the agency's relocation from London due to Brexit. The bid outlines essential criteria such as connectivity, modern facilities, and high-quality living conditions for EMA staff and families, ensuring a smooth transition and support for the agency's ongoing operations. This relocation is seen as critical for maintaining the efficacy of EU medicines regulation and safeguarding public health across Europe.